Seasonal malaria chemoprevention is one of the most cost-effective programs GiveWell has identified—but in eastern and southern Africa, we have substantial uncertainties about drug effectiveness. That’s why we’re funding the CHAMP trial, which is, to our knowledge, thelargest individually randomized trial of malaria chemoprevention drugs ever conducted.
In our latest podcast episode, GiveWell CEO and co-founder Elie Hassenfeld and Senior Researcher John Macke discuss what we hope to learn and how it could shape our malaria grantmaking. Subscribe here for the latest updates.
Generating Evidence for the Future of Malaria Prevention
GiveWell is often thought of for its Top Charities, but over the last several years, we’ve been substantially broadening our work. We’ve developed new ways to identify potential grantees, funded research to fill gaps in our understanding, and explored new program areas where we believe cost-effective opportunities exist but other funders aren’t investing.
In a recent podcast episode, GiveWell CEO and co-founder Elie Hassenfeld and Senior Program Officer Julie Faller discuss how our research approach has evolved and what it means for the future of our grantmaking.
Evolving Our Research Approach for Greater Impact
GiveWell is hiring for several positions including:
GiveWell Updates
Generating Evidence for the Future of Malaria PreventionSeasonal malaria chemoprevention is one of the most cost-effective programs GiveWell has identified—but in eastern and southern Africa, we have substantial uncertainties about drug effectiveness. That’s why we’re funding the CHAMP trial, which is, to our knowledge, the largest individually randomized trial of malaria chemoprevention drugs ever conducted.
In our latest podcast episode, GiveWell CEO and co-founder Elie Hassenfeld and Senior Researcher John Macke discuss what we hope to learn and how it could shape our malaria grantmaking. Subscribe here for the latest updates.
Evolving Our Research Approach for Greater ImpactGiveWell is often thought of for its Top Charities, but over the last several years, we’ve been substantially broadening our work. We’ve developed new ways to identify potential grantees, funded research to fill gaps in our understanding, and explored new program areas where we believe cost-effective opportunities exist but other funders aren’t investing.
In a recent podcast episode, GiveWell CEO and co-founder Elie Hassenfeld and Senior Program Officer Julie Faller discuss how our research approach has evolved and what it means for the future of our grantmaking.
GiveWell is hiring for several positions including:
Program Associate
Research Analyst
Senior Malaria Researcher
Senior Researcher